2025-03-26 03:05:24
Latest Post
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Ambo Agritec Ltd to expand presence in FMCG segment
Prism Johnson Ltd declared preferred bidder for mining lease of limestone block
Welspun Michigan Engineers Secures New Order to Upgrade the Haji Ali Storm Water Pumping Station in Mumbai
Capitalizing on Growth: Why Financial Services Firms Need a Unified AI Strategy
Stock Report
Astec LifeSciences Ltd consolidated Q4FY24 loss at Rs. 97.39 lakhs
Posted On : 2024-05-03 22:15:09( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 155.7955 crores during the period ended March 31, 2024 as compared to Rs. 51.7038 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. -0.9739 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. -24.3342 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. -0.50 for the period ended March 31, 2024 as compared to Rs. -12.41 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 155.7955 crs | ₹51.7038 crs |  201.32% |
| Net Profit | ₹-0.9739 crs | ₹-24.3342 crs |  96.00% |
| EPS | ₹-0.50 | ₹-12.41 | 95.97% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 155.7955 crores during the period ended March 31, 2024 as compared to Rs.129.5469 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.-0.9739 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.-4.9833 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.-0.50 for the period ended March 31, 2024 as compared to Rs.-2.54 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 155.7955 crs | ₹129.5469 crs | 20.26% |
| Net Profit | ₹-0.9739 crs | ₹-4.9833 crs | 80.46% |
| EPS | ₹-0.50 | ₹-2.54 | 80.31% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.463.8246 crores during the Financial Year ended March 31, 2024 as compared to Rs.641.2263 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.-46.9295 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.25.5649 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.-23.93 for the Financial Year ended March 31, 2024 as compared to Rs.13.04 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹463.8246 crs | ₹641.2263 crs |  -27.67% |
| Net Profit | ₹-46.9295 crs | ₹25.5649 crs | -283.57% |
| EPS | ₹-23.93 | ₹13.04 | -283.51% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1227.20 as compared to the previous close of Rs. 1235.00. The total number of shares traded during the day was 7223 in over 925 trades.
The stock hit an intraday high of Rs. 1290.30 and intraday low of 1216.35. The net turnover during the day was Rs. 9066168.00.
